Schlumberger shares are down 25% since the start of the year.
Shares of Gilead Sciences rose 2% Thursday after the FDA approved its Yescarta lymphoma cancer therapy drug.
Today's Top Stories: Amazon's deadline to submit a proposal to build a new headquarters is today, Gilead shares are jumping as a result of the FDA's approval of a cancer treatment, today marks the 30th anniversary of Black Monday.
The British consumer goods company is behind some of the most well-known brands on your supermarket's shelf including Veet, Lysol and Clearasil.
The Dow ended the day at all-time highs for its second session in a row, though missed out on ending above that 23,000 mark it hit earlier.
Stockpicker plans to buy more AGN if it drops another $5 or so.
The Dow, the Nasdaq and the S&P 500 all reached new record highs even though drug stocks were under pressure following comments by President Trump.
"The Department of Health and Human Services has concluded that there is no appropriation for cost-sharing reduction payments to insurance companies under Obamacare"
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks.
Amazon has its eyes on the pharmacy business. TheStreet's Jim Cramer thinks Amazon can help push for lower prices on prescriptions for consumers.